New PI Video: https://www.proactiveinvestors.co
Post# of 148187
https://www.proactiveinvestors.com/companies/...13768.html
Summary:
1) NP is back in the office
2) Discusses PrEP Thai study; could very quick process to prevention approval (post combo approval); seems like they are trying to put the pressure on Gilead; less side affects on Leronlimab compared to Truvada.
3) Trial outline: 50 patients initially potentially from large center that tests 40,000 patients checked on regular basis; protocol still in design; hope to begin study this year.